{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:11:22Z","timestamp":1793985082906,"version":"4.8.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C57799\/A27964"],"award-info":[{"award-number":["C57799\/A27964"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic rewiring is a hallmark of malignant transformation in leukemic cells and the potential offered by its therapeutic targeting has garnered significant attention. The development of clinically relevant metabolic targeted therapies in acute myeloid leukemia (AML) has mostly focused on targeting mitochondrial energy production, but progress has been hampered by generalized toxicities. An alternative strategy is to shift the focus from targeting energy production to targeting more specialized metabolic functions, such as energy storage, the regulation of oxidative stress and availability of cofactors needed for the function of specific metabolic reactions. Lipid metabolism plays a role in many of these metabolic functions and its importance in AML maintenance and response to therapy is being increasingly recognized but needs to be adequately interpreted in the context of its interaction with the microenvironment, particularly the adipose niche. In this review, we provide an overview of our current understanding of AML cellular metabolic dependencies on fatty acid and lipid metabolism and discuss their relevance in the context of functional interactions with adipocytes. We highlight unresolved questions about how to best target lipid metabolism and suggest approaches needed to fully understand the interplay between malignant cells and their niche in the context of metabolic dependencies.<\/jats:p>","DOI":"10.1038\/s41375-025-02645-z","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T03:27:59Z","timestamp":1747884479000},"page":"1814-1823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities"],"prefix":"10.1038","volume":"39","author":[{"given":"Vilma","family":"Dembitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie C.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-2253","authenticated-orcid":false,"given":"Paolo","family":"Gallipoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"2645_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41375-021-01164-x","volume":"35","author":"DGJ Cucchi","year":"2021","unstructured":"Cucchi DGJ, Polak TB, Ossenkoppele GJ, Uyl\u2013De Groot CA, Cloos J, Zweegman S, et al. Two decades of targeted therapies in acute myeloid leukemia. Leukemia. 2021;35:651\u201360.","journal-title":"Leukemia"},{"key":"2645_CR2","doi-asserted-by":"crossref","unstructured":"Turkalj S, Radtke FA, Vyas P. An overview of targeted therapies in acute myeloid leukemia. HemaSphere. 2023;7:e914.","DOI":"10.1097\/HS9.0000000000000914"},{"key":"2645_CR3","doi-asserted-by":"crossref","unstructured":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374.","DOI":"10.1056\/NEJMoa1301689"},{"key":"2645_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34:355\u201377.","journal-title":"Cell Metab"},{"key":"2645_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","volume":"20","author":"M \u0160krti\u0107","year":"2011","unstructured":"\u0160krti\u0107 M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z, et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell. 2011;20:674\u201388.","journal-title":"Cancer Cell"},{"key":"2645_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"D Lagadinou Eleni","year":"2013","unstructured":"Lagadinou Eleni D, Sach A, Callahan K, Rossi Randall M, Neering Sarah J, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12:329\u201341.","journal-title":"Cell Stem Cell"},{"key":"2645_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 2017;7:716\u201335.","journal-title":"Cancer Discov"},{"key":"2645_CR8","unstructured":"Phase 3 multicenter randomized trial to evaluate efficacy and safety of CPI-613 in combination with HD Cyt. and Mito. vs HD Cyt. and Mito. Therapy and control sub-groups in older patients With R\/R AML. 2018. https:\/\/clinicaltrials.gov\/study\/NCT03504410."},{"key":"2645_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med. 2023;29:115\u201326.","journal-title":"Nat Med"},{"key":"2645_CR10","first-page":"2343","volume":"108","author":"C O\u2019Brien","year":"2023","unstructured":"O\u2019Brien C, Ling T, Berman JM, Culp-Hill R, Reisz JA, Rondeau V, et al. Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid \u03b2-oxidation and inducing lipotoxicity. Haematologica. 2023;108:2343\u201357.","journal-title":"Haematologica"},{"key":"2645_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s43018-023-00653-5","volume":"5","author":"C Bruedigam","year":"2024","unstructured":"Bruedigam C, Porter AH, Song A, Vroeg in de Wei G, Stoll T, Straube J, et al. Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia. Nat Cancer. 2024;5:47\u201365.","journal-title":"Nat Cancer"},{"key":"2645_CR12","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1182\/blood.2021013277","volume":"139","author":"AC Lewis","year":"2022","unstructured":"Lewis AC, Pope VS, Tea MN, Li M, Nwosu GO, Nguyen TM, et al. Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia. Blood. 2022;139:3737\u201351.","journal-title":"Blood"},{"key":"2645_CR13","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1182\/blood-2006-08-044446","volume":"109","author":"SM Kornblau","year":"2006","unstructured":"Kornblau SM, Banker DE, Stirewalt D, Shen D, Lemker E, Verstovsek S, et al. Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study. Blood. 2006;109:2999\u20133006.","journal-title":"Blood"},{"key":"2645_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.leukres.2018.01.021","volume":"67","author":"AS Advani","year":"2018","unstructured":"Advani AS, Li H, Michaelis LC, Medeiros BC, Liedtke M, List AF, et al. Report of the relapsed\/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML). Leuk Res. 2018;67:17\u201320.","journal-title":"Leuk Res"},{"key":"2645_CR15","doi-asserted-by":"publisher","first-page":"eaaq1240","DOI":"10.1126\/scitranslmed.aaq1240","volume":"10","author":"JS Lee","year":"2018","unstructured":"Lee JS, Roberts A, Juarez D, Vo T-TT, Bhatt S, Herzog L-o, et al. Statins enhance efficacy of venetoclax in blood cancers. Sci Transl Med. 2018;10:eaaq1240.","journal-title":"Sci Transl Med"},{"key":"2645_CR16","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.bneo.2024.100036","volume":"1","author":"EA Brem","year":"2024","unstructured":"Brem EA, Shieh K, Juarez D, Buono R, Jeyakumar D, O\u2019Brien S, et al. A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL\/SLL: a mechanism-based drug repurposing strategy. Blood Neoplasia. 2024;1:100036.","journal-title":"Blood Neoplasia"},{"key":"2645_CR17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S0022-2275(20)40020-3","volume":"20","author":"JC Klock","year":"1979","unstructured":"Klock JC, Pieprzyk JK. Cholesterol, phospholipids, and fatty acids of normal immature neutrophils: comparison with acute myeloblastic leukemia cells and normal neutrophils. J Lipid Res. 1979;20:908\u201311.","journal-title":"J Lipid Res"},{"key":"2645_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbacli.2017.03.002","volume":"7","author":"T Pabst","year":"2017","unstructured":"Pabst T, Kortz L, Fiedler GM, Ceglarek U, Idle JR, Beyo\u011flu D. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features. BBA Clin. 2017;7:105\u201314.","journal-title":"BBA Clin"},{"key":"2645_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48970-0","volume":"13","author":"L Bolkun","year":"2023","unstructured":"Bolkun L, Pienkowski T, Sieminska J, Godzien J, Pietrowska K, K\u0142oczko J, et al. Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy. Sci Rep. 2023;13:21809.","journal-title":"Sci Rep"},{"key":"2645_CR20","doi-asserted-by":"publisher","first-page":"e0168781","DOI":"10.1371\/journal.pone.0168781","volume":"12","author":"A Stefanko","year":"2017","unstructured":"Stefanko A, Thiede C, Ehninger G, Simons K, Grzybek M. Lipidomic approach for stratification of acute myeloid leukemia patients. PLOS ONE. 2017;12:e0168781.","journal-title":"PLOS ONE"},{"key":"2645_CR21","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","volume":"1","author":"BM Stevens","year":"2020","unstructured":"Stevens BM, Jones CL, Pollyea DA, Culp-Hill R, D\u2019Alessandro A, Winters A, et al. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nat Cancer. 2020;1:1176\u201387.","journal-title":"Nat Cancer"},{"key":"2645_CR22","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1182\/blood-2014-12-617498","volume":"126","author":"MR Ricciardi","year":"2015","unstructured":"Ricciardi MR, Mirabilii S, Allegretti M, Licchetta R, Calarco A, Torrisi MR, et al. Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias. Blood. 2015;126:1925\u20139.","journal-title":"Blood"},{"key":"2645_CR23","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41375-024-02390-9","volume":"38","author":"V Dembitz","year":"2024","unstructured":"Dembitz V, Lawson H, Burt R, Natani S, Philippe C, James SC, et al. Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation. Leukemia. 2024;38:2395\u2013409.","journal-title":"Leukemia"},{"key":"2645_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physiol.00014.2006","volume":"21","author":"H Doege","year":"2006","unstructured":"Doege H, Stahl A. Protein-mediated fatty acid uptake: novel insights from in vivo models. Physiology. 2006;21:259\u201368.","journal-title":"Physiology"},{"key":"2645_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-physiol-032122-030352","volume":"85","author":"D Samovski","year":"2023","unstructured":"Samovski D, Jacome-Sosa M, Abumrad NA. Fatty acid transport and signaling: mechanisms and physiological implications. Annu Rev Physiol. 2023;85:317\u201337.","journal-title":"Annu Rev Physiol"},{"key":"2645_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18565-8","volume":"11","author":"J-W Hao","year":"2020","unstructured":"Hao J-W, Wang J, Guo H, Zhao Y-Y, Sun H-H, Li Y-F, et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis. Nat Commun. 2020;11:4765.","journal-title":"Nat Commun"},{"key":"2645_CR27","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.exphem.2007.04.003","volume":"35","author":"L Chen","year":"2007","unstructured":"Chen L, Gao Z, Zhu J, Rodgers GP. Identification of CD13+CD36+ cells as a common progenitor for erythroid and myeloid lineages in human bone marrow. Exp Hematol. 2007;35:1047\u201355.","journal-title":"Exp Hematol"},{"key":"2645_CR28","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/stem.1716","volume":"32","author":"JS Hale","year":"2014","unstructured":"Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, et al. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells. 2014;32:1746\u201358.","journal-title":"Stem Cells"},{"key":"2645_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S, Mart\u00edn M, Castellanos A, Attolini CS-O, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541:41\u201345.","journal-title":"Nature"},{"key":"2645_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1158\/1535-7163.MCT-10-0802","volume":"10","author":"NB Kuemmerle","year":"2011","unstructured":"Kuemmerle NB, Rysman E, Lombardo PS, Flanagan AJ, Lipe BC, Wells WA, et al. Lipoprotein lipase links dietary fat to solid tumor cell proliferation. Mol Cancer Therapeutics. 2011;10:427\u201336.","journal-title":"Mol Cancer Therapeutics"},{"key":"2645_CR31","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon H, Shaw JL, Haigis MC, Greka A. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity. Mol Cell. 2021;81:3708\u201330.","journal-title":"Mol Cell"},{"key":"2645_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122:4\u201322.","journal-title":"Br J Cancer"},{"key":"2645_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16:732\u201349.","journal-title":"Nat Rev Cancer"},{"key":"2645_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1884-5","volume":"17","author":"J Wang","year":"2019","unstructured":"Wang J, Ye W, Yan X, Guo Q, Ma Q, Lin F, et al. Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia. J Transl Med. 2019;17:149.","journal-title":"J Transl Med"},{"key":"2645_CR35","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1182\/blood-2024-200731","volume":"144","author":"M Su","year":"2024","unstructured":"Su M, Lv Z, Lu Y, Xie X, Ouyang J, Zhong P, et al. Fatty acid synthase (FASN) maintains leukemogenesis by suppressing progranulin-engaged lysosomal and inflammatory signaling. Blood. 2024;144:5721.","journal-title":"Blood"},{"key":"2645_CR36","doi-asserted-by":"publisher","first-page":"e141529","DOI":"10.1172\/JCI141529","volume":"131","author":"H Ito","year":"2021","unstructured":"Ito H, Nakamae I, Kato J-Y, Yoneda-Kato N. Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development. J Clin Investig. 2021;131:e141529.","journal-title":"J Clin Investig"},{"key":"2645_CR37","doi-asserted-by":"publisher","first-page":"25339","DOI":"10.1074\/jbc.M501159200","volume":"280","author":"N Scaglia","year":"2005","unstructured":"Scaglia N, Igal RA. Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed. Cells J Biol Chem. 2005;280:25339\u201349.","journal-title":"Cells J Biol Chem"},{"key":"2645_CR38","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1158\/1541-7786.MCR-11-0126","volume":"9","author":"UV Roongta","year":"2011","unstructured":"Roongta UV, Pabalan JG, Wang X, Ryseck R-P, Fargnoli J, Henley BJ, et al. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res. 2011;9:1551\u201361.","journal-title":"Mol Cancer Res"},{"key":"2645_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10549-012-2354-4","volume":"137","author":"AM Holder","year":"2013","unstructured":"Holder AM, Gonzalez-Angulo AM, Chen H, Akcakanat A, Do K-A, Fraser Symmans W, et al. High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients. Breast Cancer Res Treat. 2013;137:319\u201327.","journal-title":"Breast Cancer Res Treat"},{"key":"2645_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11010-018-3306-z","volume":"447","author":"M Presler","year":"2018","unstructured":"Presler M, Wojtczyk-Miaskowska A, Schlichtholz B, Kaluzny A, Matuszewski M, Mika A, et al. Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer. Mol Cell Biochem. 2018;447:217\u201324.","journal-title":"Mol Cell Biochem"},{"key":"2645_CR41","doi-asserted-by":"publisher","first-page":"E697","DOI":"10.1210\/jc.2014-2764","volume":"100","author":"CA von Roemeling","year":"2015","unstructured":"von Roemeling CA, Marlow LA, Pinkerton AB, Crist A, Miller J, Tun HW, et al. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol Metab. 2015;100:E697\u2013E709.","journal-title":"J Clin Endocrinol Metab"},{"key":"2645_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","volume":"566","author":"K Vriens","year":"2019","unstructured":"Vriens K, Christen S, Parik S, Broekaert D, Yoshinaga K, Talebi A, et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature. 2019;566:403\u20136.","journal-title":"Nature"},{"key":"2645_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-023-01789-0","volume":"22","author":"E Chen","year":"2023","unstructured":"Chen E, Wang C, Lv H, Yu J. The role of fatty acid desaturase 2 in multiple tumor types revealed by bulk and single-cell transcriptomes. Lipids Health Dis. 2023;22:25.","journal-title":"Lipids Health Dis"},{"key":"2645_CR44","doi-asserted-by":"crossref","unstructured":"Heravi G, Jang H, Wang X, Long Z, Peng Z, Kim S, et al. Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment. Front Oncol. 2022;12:942798.","DOI":"10.3389\/fonc.2022.942798"},{"key":"2645_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbalip.2015.11.007","volume":"1861","author":"HG Park","year":"2016","unstructured":"Park HG, Kothapalli KSD, Park WJ, DeAllie C, Liu L, Liang A, et al. Palmitic acid (16:0) competes with omega-6 linoleic and omega-3 \u0251-linolenic acids for FADS2 mediated \u03946-desaturation. Biochim Biophys Acta Mol Cell Biol Lipids. 2016;1861:91\u201397.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2645_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1210\/en.2006-0998","volume":"148","author":"LI Rachek","year":"2007","unstructured":"Rachek LI, Musiyenko SI, LeDoux SP, Wilson GL. Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in L6 rat skeletal muscle cells. Endocrinology. 2007;148:293\u20139.","journal-title":"Endocrinology"},{"key":"2645_CR47","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/sj.ejcn.1600783","volume":"53","author":"A Jenkinson","year":"1999","unstructured":"Jenkinson A, Franklin MF, Wahle K, Duthie GG. Dietary intakes of polyunsaturated fatty acids and indices of oxidative stress in human volunteers. Eur J Clin Nutr. 1999;53:523\u20138.","journal-title":"Eur J Clin Nutr"},{"key":"2645_CR48","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci. 2016;113:E4966\u2013E4975.","journal-title":"Proc Natl Acad Sci"},{"key":"2645_CR49","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, Ko P-J, To M, Cao JY, Forcina GC, Tarangelo A, et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem Biol. 2019;26:420\u2013.e429.","journal-title":"Cell Chem Biol"},{"key":"2645_CR50","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1073\/pnas.1217611110","volume":"110","author":"R Volmer","year":"2013","unstructured":"Volmer R, van der Ploeg K, Ron D. Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains. Proc Natl Acad Sci. 2013;110:4628\u201333.","journal-title":"Proc Natl Acad Sci"},{"key":"2645_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0624-1","volume":"16","author":"M W\u0105tek","year":"2017","unstructured":"W\u0105tek M, Durna\u015b B, Wollny T, Pasiarski M, G\u00f3\u017ad\u017a S, Marzec M, et al. Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia. Lipids Health Dis. 2017;16:235.","journal-title":"Lipids Health Dis"},{"key":"2645_CR52","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1182\/bloodadvances.2023010535","volume":"8","author":"BB Paudel","year":"2024","unstructured":"Paudel BB, Tan S-F, Fox TE, Ung J, Golla U, Shaw JJP, et al. Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes. Blood Adv. 2024;8:1137\u201342.","journal-title":"Blood Adv"},{"key":"2645_CR53","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.chembiol.2015.11.004","volume":"22","author":"V del Solar","year":"2015","unstructured":"del Solar V, Lizardo Darleny Y, Li N, Hurst Jerod J, Brais Christopher J, Atilla-Gokcumen GE. Differential regulation of specific sphingolipids in colon cancer cells during staurosporine-induced apoptosis. Chem Biol. 2015;22:1662\u201370.","journal-title":"Chem Biol"},{"key":"2645_CR54","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41419-024-06810-7","volume":"15","author":"GO Nwosu","year":"2024","unstructured":"Nwosu GO, Ross DM, Powell JA, Pitson SM. Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia. Cell Death Dis. 2024;15:413.","journal-title":"Cell Death Dis"},{"key":"2645_CR55","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.trecan.2016.05.009","volume":"2","author":"N Thapa","year":"2016","unstructured":"Thapa N, Tan X, Choi S, Lambert PF, Rapraeger AC, Anderson RA. The hidden conundrum of phosphoinositide signaling in cancer. Trends Cancer. 2016;2:378\u201390.","journal-title":"Trends Cancer"},{"key":"2645_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ceb.2019.12.007","volume":"63","author":"GRV Hammond","year":"2020","unstructured":"Hammond GRV, Burke JE. Novel roles of phosphoinositides in signaling, lipid transport, and disease. Curr Opin Cell Biol. 2020;63:57\u201367.","journal-title":"Curr Opin Cell Biol"},{"key":"2645_CR57","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s12276-023-01018-9","volume":"55","author":"M Lee","year":"2023","unstructured":"Lee M, Lee SY, Bae Y-S. Functional roles of sphingolipids in immunity and their implication in disease. Exp Mol Med. 2023;55:1110\u201330.","journal-title":"Exp Mol Med"},{"key":"2645_CR58","doi-asserted-by":"publisher","first-page":"e2226","DOI":"10.1038\/cddis.2016.132","volume":"7","author":"Q Qu","year":"2016","unstructured":"Qu Q, Zeng F, Liu X, Wang QJ, Deng F. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis. 2016;7:e2226\u2013e2226.","journal-title":"Cell Death Dis"},{"key":"2645_CR59","doi-asserted-by":"crossref","unstructured":"Chandel NS. Lipid Metabolism. Cold Spring Harbor Perspect Biol. 2021;13:a040576.","DOI":"10.1101\/cshperspect.a040576"},{"key":"2645_CR60","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/jcp.21.5.643","volume":"21","author":"DH Wright","year":"1968","unstructured":"Wright DH. Lipid content of malignant lymphomas. J Clin Pathol. 1968;21:643.","journal-title":"J Clin Pathol"},{"key":"2645_CR61","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","volume":"7","author":"T Simsek","year":"2010","unstructured":"Simsek T, Kocabas F, Zheng J, DeBerardinis RJ, Mahmoud AI, Olson EN, et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell. 2010;7:380\u201390.","journal-title":"Cell Stem Cell"},{"key":"2645_CR62","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1182\/blood.V104.11.369.369","volume":"104","author":"K Ito","year":"2004","unstructured":"Ito K, Hirao A, Arai F, Matsuoka S, Mak TW, Suda T. Regulation of oxidative stress by ATM is required for the self-renewal of haematopoietic stem cells. Blood. 2004;104:369.","journal-title":"Blood"},{"key":"2645_CR63","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1182\/blood-2007-05-087759","volume":"110","author":"Y-Y Jang","year":"2007","unstructured":"Jang Y-Y, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood. 2007;110:3056\u201363.","journal-title":"Blood"},{"key":"2645_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13125","volume":"7","author":"N Vannini","year":"2016","unstructured":"Vannini N, Girotra M, Naveiras O, Nikitin G, Campos V, Giger S, et al. Specification of haematopoietic stem cell fate via modulation of mitochondrial activity. Nat Commun. 2016;7:13125.","journal-title":"Nat Commun"},{"key":"2645_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27460-9","volume":"12","author":"JJ Mistry","year":"2021","unstructured":"Mistry JJ, Hellmich C, Moore JA, Jibril A, Macaulay I, Moreno-Gonzalez M, et al. Free fatty-acid transport via CD36 drives \u03b2-oxidation-mediated hematopoietic stem cell response to infection. Nat Commun. 2021;12:7130.","journal-title":"Nat Commun"},{"key":"2645_CR66","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Reisz JA, Culp-Hill R, Nemkov T, et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell. 2018;34:724\u2013.e724.","journal-title":"Cancer Cell"},{"key":"2645_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53535-4","volume":"15","author":"R Wegmann","year":"2024","unstructured":"Wegmann R, Bonilla X, Casanova R, Chevrier S, Coelho R, Esposito C, et al. Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia. Nat Commun. 2024;15:9402.","journal-title":"Nat Commun"},{"key":"2645_CR68","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2020.07.009","volume":"32","author":"N van Gastel","year":"2020","unstructured":"van Gastel N, Spinelli JB, Sharda A, Schajnovitz A, Baryawno N, Rhee C, et al. Induction of a timed metabolic collapse to overcome cancer chemoresistance. Cell Metab. 2020;32:391\u2013403.e396.","journal-title":"Cell Metab"},{"key":"2645_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ebiom.2016.11.025","volume":"14","author":"J Shi","year":"2016","unstructured":"Shi J, Fu H, Jia Z, He K, Fu L, Wang W. High expression of CPT1A predicts adverse outcomes: a potential therapeutic target for acute myeloid leukemia. eBioMedicine. 2016;14:55\u201364.","journal-title":"eBioMedicine"},{"key":"2645_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02848-9","volume":"19","author":"S Mao","year":"2021","unstructured":"Mao S, Ling Q, Pan J, Li F, Huang S, Ye W, et al. Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199. J Transl Med. 2021;19:181.","journal-title":"J Transl Med"},{"key":"2645_CR71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1527-3466.2007.00006.x","volume":"25","author":"H Ashrafian","year":"2007","unstructured":"Ashrafian H, Horowitz JD, Frenneaux MP. Perhexiline. Cardiovasc Drug Rev. 2007;25:76\u201397.","journal-title":"Cardiovasc Drug Rev"},{"key":"2645_CR72","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/CS20060307","volume":"113","author":"JF Holubarsch Christian","year":"2007","unstructured":"Holubarsch Christian JF, Rohrbach M, Karrasch M, Boehm E, Polonski L, Ponikowski P, et al. A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study. Clin Sci. 2007;113:205\u201312.","journal-title":"Clin Sci"},{"key":"2645_CR73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metab. 2020;31:62\u201376.","journal-title":"Cell Metab"},{"key":"2645_CR74","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","volume":"125","author":"S Sriskanthadevan","year":"2015","unstructured":"Sriskanthadevan S, Jeyaraju DV, Chung TE, Prabha S, Xu W, Skrtic M, et al. AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress. Blood. 2015;125:2120\u201330.","journal-title":"Blood"},{"key":"2645_CR75","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2015.1054549","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu Y, Xie Y, Cao L, Yang L, Yang M, Lotze MT, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2:e1054549.","journal-title":"Mol Cell Oncol"},{"key":"2645_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37652-0","volume":"14","author":"K Woodley","year":"2023","unstructured":"Woodley K, Dillingh LS, Giotopoulos G, Madrigal P, Rattigan KM, Philippe C, et al. Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death. Nat Commun. 2023;14:2132.","journal-title":"Nat Commun"},{"key":"2645_CR77","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1158\/2159-8290.CD-22-0411","volume":"13","author":"M Sabatier","year":"2023","unstructured":"Sabatier M, Birsen R, Lauture L, Mouche S, Angelino P, Dehairs J, et al. C\/EBP\u03b1 confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress\u2013induced ferroptosis in FLT3-mutant leukemia. Cancer Discov. 2023;13:1720\u201347.","journal-title":"Cancer Discov"},{"key":"2645_CR78","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3324\/haematol.2020.259531","volume":"107","author":"R Birsen","year":"2022","unstructured":"Birsen R, Larrue C, Decroocq J, Johnson N, Guiraud N, Gotanegre M, et al. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica. 2022;107:403\u201316.","journal-title":"Haematologica"},{"key":"2645_CR79","unstructured":"Phase I trial of SCD I: a first in human dose regimen-finding study to evaluate the safety, tolerability, pharmacokinetics, and activity of MTI-301 in patients with advanced malignancy. In: National Cancer I, editor. 2025. https:\/\/clinicaltrials.gov\/study\/NCT06911008."},{"key":"2645_CR80","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/metabo13040467","volume":"13","author":"R Culp-Hill","year":"2023","unstructured":"Culp-Hill R, Stevens BM, Jones CL, Pei S, Dzieciatkowska M, Minhajuddin M, et al. Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2. Metabolites. 2023;13:467.","journal-title":"Metabolites"},{"key":"2645_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107214","volume":"300","author":"J Kanefsky","year":"2024","unstructured":"Kanefsky J, Basse M, Sokei J, di Martino O, Valin L, Jaspers Y, et al. Disruption of polyunsaturated fatty acid biosynthesis drives STING-dependent acute myeloid leukemia cell maturation and death. J Biol Chem. 2024;300:107214.","journal-title":"J Biol Chem"},{"key":"2645_CR82","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1079\/BJN19870046","volume":"57","author":"J Leyton","year":"1987","unstructured":"Leyton J, Drury PJ, Crawford MA. Differential oxidation of saturated and unsaturated fatty acids in vivo in the rat. Br J Nutr. 1987;57:383\u201393.","journal-title":"Br J Nutr"},{"key":"2645_CR83","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cmet.2018.12.023","volume":"29","author":"W Kim","year":"2019","unstructured":"Kim W, Deik A, Gonzalez C, Gonzalez ME, Fu F, Ferrari M, et al. Polyunsaturated Fatty Acid Desaturation Is a Mechanism for Glycolytic NAD+ Recycling. Cell Metab. 2019;29:856\u2013.e857.","journal-title":"Cell Metab"},{"key":"2645_CR84","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.stem.2020.07.021","volume":"27","author":"CL Jones","year":"2020","unstructured":"Jones CL, Stevens BM, Pollyea DA, Culp-Hill R, Reisz JA, Nemkov T, et al. Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells. Cell Stem Cell. 2020;27:748\u2013764.e744.","journal-title":"Cell Stem Cell"},{"key":"2645_CR85","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.stem.2021.06.004","volume":"28","author":"A Subedi","year":"2021","unstructured":"Subedi A, Liu Q, Ayyathan DM, Sharon D, Cathelin S, Hosseini M, et al. Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis. Cell Stem Cell. 2021;28:1851\u20131867.e1858.","journal-title":"Cell Stem Cell"},{"key":"2645_CR86","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41556-024-01364-4","volume":"26","author":"AJ Mathiowetz","year":"2024","unstructured":"Mathiowetz AJ, Olzmann JA. Lipid droplets and cellular lipid flux. Nat Cell Biol. 2024;26:331\u201345.","journal-title":"Nat Cell Biol"},{"key":"2645_CR87","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.celrep.2018.08.015","volume":"24","author":"D Ackerman","year":"2018","unstructured":"Ackerman D, Tumanov S, Qiu B, Michalopoulou E, Spata M, Azzam A, et al. Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation. Cell Rep. 2018;24:2596\u20132605.e2595.","journal-title":"Cell Rep"},{"key":"2645_CR88","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1182\/blood-2024-206473","volume":"144","author":"C Bruedigam","year":"2024","unstructured":"Bruedigam C, Dulatre EA, Lee C, Porter AH, Lim ELSP, Shi AZ, et al. Overcoming Ven\/Aza resistance through imetelstat-mediated lipophagy in acute myeloid leukemia. Blood. 2024;144:52\u201352.","journal-title":"Blood"},{"key":"2645_CR89","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1182\/blood-2024-208239","volume":"144","author":"D Sternadt","year":"2024","unstructured":"Sternadt D, Pereira-Martins DA, Silveira DRA, Weinhaeuser I, Yang M, Chatzikyriakou P, et al. DGAT1 inhibition enhances metformin-induced ferroptosis in AML By targeting lipid metabolism. Blood. 2024;144:1393\u20131393.","journal-title":"Blood"},{"key":"2645_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2019.101017","volume":"77","author":"PL Else","year":"2020","unstructured":"Else PL. The highly unnatural fatty acid profile of cells in culture. Prog Lipid Res. 2020;77:101017.","journal-title":"Prog Lipid Res"},{"key":"2645_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8808","volume":"6","author":"EL Scheller","year":"2015","unstructured":"Scheller EL, Doucette CR, Learman BS, Cawthorn WP, Khandaker S, Schell B, et al. Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues. Nat Commun. 2015;6:7808.","journal-title":"Nat Commun"},{"key":"2645_CR92","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.celrep.2019.12.089","volume":"30","author":"C Attan\u00e9","year":"2020","unstructured":"Attan\u00e9 C, Est\u00e8ve D, Chaoui K, Iacovoni JS, Corre J, Moutahir M, et al. Human bone marrow is comprised of adipocytes with specific lipid metabolism. Cell Rep. 2020;30:949\u2013958.e946.","journal-title":"Cell Rep"},{"key":"2645_CR93","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bone.2018.01.016","volume":"118","author":"EL Scheller","year":"2019","unstructured":"Scheller EL, Khandaker S, Learman BS, Cawthorn WP, Anderson LM, Pham HA, et al. Bone marrow adipocytes resist lipolysis and remodeling in response to \u03b2-adrenergic stimulation. Bone. 2019;118:32\u201341.","journal-title":"Bone"},{"key":"2645_CR94","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tem.2016.03.016","volume":"27","author":"EL Scheller","year":"2016","unstructured":"Scheller EL, Cawthorn WP, Burr AA, Horowitz MC, MacDougald OA. Marrow adipose tissue: trimming the fat. Trends Endocrinol Metab. 2016;27:392\u2013403.","journal-title":"Trends Endocrinol Metab"},{"key":"2645_CR95","doi-asserted-by":"crossref","unstructured":"Tratwal J, Falgayrac G, During A, Bertheaume N, Bataclan C, Tavakol DN, et al. Raman microspectroscopy reveals unsaturation heterogeneity at the lipid droplet level and validates an in vitro model of bone marrow adipocyte subtypes. Front Endocrinol. 2022;13:1001210.","DOI":"10.3389\/fendo.2022.1001210"},{"key":"2645_CR96","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10555-022-10042-6","volume":"41","author":"M Hernandez","year":"2022","unstructured":"Hernandez M, Shin S, Muller C, Attan\u00e9 C. The role of bone marrow adipocytes in cancer progression: the impact of obesity. Cancer Metastasis Rev. 2022;41:589\u2013605.","journal-title":"Cancer Metastasis Rev"},{"key":"2645_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100629","volume":"2","author":"C Attan\u00e9","year":"2021","unstructured":"Attan\u00e9 C, Est\u00e8ve D, Moutahir M, Reina N, Muller C. A protocol for human bone marrow adipocyte isolation and purification. STAR Protoc. 2021;2:100629.","journal-title":"STAR Protoc"},{"key":"2645_CR98","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nature08099","volume":"460","author":"O Naveiras","year":"2009","unstructured":"Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009;460:259\u201363.","journal-title":"Nature"},{"key":"2645_CR99","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.stem.2017.02.009","volume":"20","author":"TH Ambrosi","year":"2017","unstructured":"Ambrosi TH, Scialdone A, Graja A, Gohlke S, Jank A-M, Bocian C, et al. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell. 2017;20:771\u2013784.e776.","journal-title":"Cell Stem Cell"},{"key":"2645_CR100","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/jcp.26037","volume":"233","author":"D Mattiucci","year":"2018","unstructured":"Mattiucci D, Maurizi G, Izzi V, Cenci L, Ciarlantini M, Mancini S, et al. Bone marrow adipocytes support hematopoietic stem cell survival. J Cell Physiol. 2018;233:1500\u201311.","journal-title":"J Cell Physiol"},{"key":"2645_CR101","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1073\/pnas.1205129109","volume":"109","author":"MD Trottier","year":"2012","unstructured":"Trottier MD, Naaz A, Li Y, Fraker PJ. Enhancement of hematopoiesis and lymphopoiesis in diet-induced obese mice. Proc Natl Acad Sci. 2012;109:7622\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"2645_CR102","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41556-019-0439-6","volume":"22","author":"C Baccin","year":"2020","unstructured":"Baccin C, Al-Sabah J, Velten L, Helbling PM, Gr\u00fcnschl\u00e4ger F, Hern\u00e1ndez-Malmierca P, et al. Combined single-cell and spatial transcriptomics reveal the molecular, cellular and spatial bone marrow niche organization. Nat Cell Biol. 2020;22:38\u201348.","journal-title":"Nat Cell Biol"},{"key":"2645_CR103","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54695","volume":"9","author":"L Zhong","year":"2020","unstructured":"Zhong L, Yao L, Tower RJ, Wei Y, Miao Z, Park J, et al. Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment. eLife. 2020;9:e54695.","journal-title":"eLife"},{"key":"2645_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36906-1","volume":"14","author":"N Zioni","year":"2023","unstructured":"Zioni N, Bercovich AA, Chapal-Ilani N, Bacharach T, Rappoport N, Solomon A, et al. Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis. Nat Commun. 2023;14:2070.","journal-title":"Nat Commun"},{"key":"2645_CR105","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.stemcr.2020.06.011","volume":"15","author":"AG Aguilar-Navarro","year":"2020","unstructured":"Aguilar-Navarro AG, Meza-Le\u00f3n B, Gratzinger D, Ju\u00e1rez-Aguilar FG, Chang Q, Ornatsky O, et al. Human aging alters the spatial organization between CD34+ hematopoietic cells and adipocytes in bone marrow. Stem Cell Rep. 2020;15:317\u201325.","journal-title":"Stem Cell Rep"},{"key":"2645_CR106","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17:1498\u2013503.","journal-title":"Nat Med"},{"key":"2645_CR107","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10585-015-9714-5","volume":"32","author":"AL Hardaway","year":"2015","unstructured":"Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. Clin Exp Metastasis. 2015;32:353\u201368.","journal-title":"Clin Exp Metastasis"},{"key":"2645_CR108","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI38942","volume":"120","author":"I Samudio","year":"2010","unstructured":"Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Investig. 2010;120:142\u201356.","journal-title":"J Clin Investig"},{"key":"2645_CR109","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1158\/0008-5472.CAN-16-1645","volume":"77","author":"Y Tabe","year":"2017","unstructured":"Tabe Y, Yamamoto S, Saitoh K, Sekihara K, Monma N, Ikeo K, et al. Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells. Cancer Res. 2017;77:1453\u201364.","journal-title":"Cancer Res"},{"key":"2645_CR110","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1182\/blood-2016-08-734798","volume":"129","author":"MS Shafat","year":"2017","unstructured":"Shafat MS, Oellerich T, Mohr S, Robinson SD, Edwards DR, Marlein CR, et al. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. Blood. 2017;129:1320\u201332.","journal-title":"Blood"},{"key":"2645_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58689-1","volume":"14","author":"H \u00c5backa","year":"2024","unstructured":"\u00c5backa H, Masoni S, Poli G, Huang P, Gusso F, Granchi C, et al. SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia. Sci Rep. 2024;14:9104.","journal-title":"Sci Rep"},{"key":"2645_CR112","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13046-018-0738-y","volume":"37","author":"W Lu","year":"2018","unstructured":"Lu W, Wan Y, Li Z, Zhu B, Yin C, Liu H, et al. Growth differentiation factor 15 contributes to marrow adipocyte remodeling in response to the growth of leukemic cells. J Exp Clin Cancer Res. 2018;37:66.","journal-title":"J Exp Clin Cancer Res"},{"key":"2645_CR113","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.3324\/haematol.2019.225763","volume":"105","author":"Y Shaoxin","year":"2020","unstructured":"Shaoxin Y, Wei L, Chong Z, Yuanmei Z, Yanyu W, Jiali L, et al. Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis. Haematologica. 2020;105:2572\u201383.","journal-title":"Haematologica"},{"key":"2645_CR114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","volume":"19","author":"H Ye","year":"2016","unstructured":"Ye H, Adane B, Khan N, Sullivan T, Minhajuddin M, Gasparetto M, et al. Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell. 2016;19:23\u201337.","journal-title":"Cell Stem Cell"},{"key":"2645_CR115","first-page":"e21","volume":"103","author":"L Wei","year":"2017","unstructured":"Wei L, Wei W, Qi Z, Yuanmei Z, Yun W, Haiyan L, et al. Small bone marrow adipocytes predict poor prognosis in acute myeloid leukemia. Haematologica. 2017;103:e21\u2013e24.","journal-title":"Haematologica"},{"key":"2645_CR116","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41375-019-0568-8","volume":"34","author":"M Azadniv","year":"2020","unstructured":"Azadniv M, Myers JR, McMurray HR, Guo N, Rock P, Coppage ML, et al. Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support. Leukemia. 2020;34:391\u2013403.","journal-title":"Leukemia"},{"key":"2645_CR117","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12015-015-9639-z","volume":"12","author":"Y Le","year":"2016","unstructured":"Le Y, Fraineau S, Chandran P, Sabloff M, Brand M, Lavoie JR, et al. Adipogenic mesenchymal stromal cells from bone marrow and their hematopoietic supportive role: towards understanding the permissive marrow microenvironment in acute myeloid leukemia. Stem Cell Rev Rep. 2016;12:235\u201344.","journal-title":"Stem Cell Rev Rep"},{"key":"2645_CR118","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/2211-5463.13165","volume":"11","author":"Z-p Pan","year":"2021","unstructured":"Pan Z-p, Wang B, Hou D-y, You R-l, Wang X-t, Xie W-h, et al. METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia. FEBS Open Bio. 2021;11:1659\u201372.","journal-title":"FEBS Open Bio"},{"key":"2645_CR119","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90036","volume":"2","author":"VL Battula","year":"2017","unstructured":"Battula VL, Le PM, Sun JC, Nguyen K, Yuan B, Zhou X, et al. AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth. JCI Insight. 2017;2:e90036.","journal-title":"JCI Insight"},{"key":"2645_CR120","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ncb3625","volume":"19","author":"AL Boyd","year":"2017","unstructured":"Boyd AL, Reid JC, Salci KR, Aslostovar L, Benoit YD, Shapovalova Z, et al. Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche. Nat Cell Biol. 2017;19:1336\u201347.","journal-title":"Nat Cell Biol"},{"key":"2645_CR121","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1158\/1541-7786.MCR-17-0338","volume":"15","author":"X Sheng","year":"2017","unstructured":"Sheng X, Parmentier J-H, Tucci J, Pei H, Cortez-Toledo O, Dieli-Conwright CM, et al. Adipocytes sequester and metabolize the chemotherapeutic daunorubicin. Mol Cancer Res. 2017;15:1704\u201313.","journal-title":"Mol Cancer Res"},{"key":"2645_CR122","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1158\/0008-5472.CAN-09-0800","volume":"69","author":"JW Behan","year":"2009","unstructured":"Behan JW, Yun JP, Proektor MP, Ehsanipour EA, Arutyunyan A, Moses AS, et al. Adipocytes impair leukemia treatment in mice. Cancer Res. 2009;69:7867\u201374.","journal-title":"Cancer Res"},{"key":"2645_CR123","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/jmri.24071","volume":"38","author":"PJ Bolan","year":"2013","unstructured":"Bolan PJ, Arentsen L, Sueblinvong T, Zhang Y, Moeller S, Carter JS, et al. Water\u2013fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients. J Magn Reson Imaging. 2013;38:1578\u201384.","journal-title":"J Magn Reson Imaging"},{"key":"2645_CR124","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","volume":"388","author":"E Nissen Steven","year":"2023","unstructured":"Nissen Steven E, Lincoff AM, Brennan D, Ray Kausik K, Mason D, Kastelein John JP, et al. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med. 2023;388:1353\u201364.","journal-title":"N Engl J Med"},{"key":"2645_CR125","doi-asserted-by":"publisher","first-page":"e056159","DOI":"10.1136\/bmjopen-2021-056159","volume":"12","author":"NB Amin","year":"2022","unstructured":"Amin NB, Darekar A, Anstee QM, Wong VW-S, Tacke F, Vourvahis M, et al. Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study. BMJ Open. 2022;12:e056159.","journal-title":"BMJ Open"},{"key":"2645_CR126","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jhep.2022.04.003","volume":"77","author":"N Alkhouri","year":"2022","unstructured":"Alkhouri N, Herring R, Kabler H, Kayali Z, Hassanein T, Kohli A, et al. Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: a randomised, open-label phase II trial. J Hepatol. 2022;77:607\u201318.","journal-title":"J Hepatol"},{"key":"2645_CR127","unstructured":"A phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of denifanstat in patients with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and F2\/F3 fibrosis (FASCINATE-3). 2024. https:\/\/clinicaltrials.gov\/study\/NCT06594523."},{"key":"2645_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100797","volume":"34","author":"G Falchook","year":"2021","unstructured":"Falchook G, Infante J, Arkenau H-T, Patel MR, Dean E, Borazanci E, et al. First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors. eClinicalMedicine. 2021;34:100797.","journal-title":"eClinicalMedicine"},{"key":"2645_CR129","unstructured":"A phase III randomized, double-blind, placebo-controlled, multi-center trial to evaluate safety and efficacy of ASC40 tablets combined with bevacizumab in subjects with recurrent glioblastoma. 2021. https:\/\/clinicaltrials.gov\/study\/NCT05118776."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02645-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02645-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02645-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:41:58Z","timestamp":1757173318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02645-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":129,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2645"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02645-z","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"VD and PG are inventors on a patent application filed for novel therapeutic approaches leveraging fatty acid metabolism in AML (PCT\/US2024\/037898).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}